Literature DB >> 17234767

The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells.

Hagen Kulbe1, Richard Thompson, Julia L Wilson, Stephen Robinson, Thorsten Hagemann, Rewas Fatah, David Gould, Ayse Ayhan, Frances Balkwill.   

Abstract

Constitutive expression of the inflammatory cytokine tumor necrosis factor-alpha (TNF-alpha) is characteristic of malignant ovarian surface epithelium. We investigated the hypothesis that this autocrine action of TNF-alpha generates and sustains a network of other mediators that promote peritoneal cancer growth and spread. When compared with two ovarian cancer cell lines that did not make TNF-alpha, constitutive production of TNF-alpha was associated with greater release of the chemokines CCL2 and CXCL12, the cytokines interleukin-6 (IL-6) and macrophage migration-inhibitory factor (MIF), and the angiogenic factor vascular endothelial growth factor (VEGF). TNF-alpha production was associated also with increased peritoneal dissemination when the ovarian cancer cells were xenografted. We next used RNA interference to generate stable knockdown of TNF-alpha in ovarian cancer cells. Production of CCL2, CXCL12, VEGF, IL-6, and MIF was decreased significantly in these cells compared with wild-type or mock-transfected cells, but in vitro growth rates were unaltered. Tumor growth and dissemination in vivo were significantly reduced when stable knockdown of TNF-alpha was achieved. Tumors derived from TNF-alpha knockdown cells were noninvasive and well circumscribed and showed high levels of apoptosis, even in the smallest deposits. This was reflected in reduced vascularization of TNF-alpha knockdown tumors. Furthermore, culture supernatants from such cells failed to stimulate endothelial cell growth in vitro. We conclude that autocrine production of TNF-alpha by ovarian cancer cells stimulates a constitutive network of other cytokines, angiogenic factors, and chemokines that may act in an autocrine/paracrine manner to promote colonization of the peritoneum and neovascularization of developing tumor deposits.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17234767      PMCID: PMC2679985          DOI: 10.1158/0008-5472.CAN-06-2941

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  29 in total

1.  Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK.

Authors:  Thorsten Hagemann; Julia Wilson; Hagen Kulbe; Ningfeng Fiona Li; David A Leinster; Kellie Charles; Florian Klemm; Tobias Pukrop; Claudia Binder; Frances R Balkwill
Journal:  J Immunol       Date:  2005-07-15       Impact factor: 5.422

Review 2.  Macrophages: obligate partners for tumor cell migration, invasion, and metastasis.

Authors:  John Condeelis; Jeffrey W Pollard
Journal:  Cell       Date:  2006-01-27       Impact factor: 41.582

3.  The response of human epithelial cells to TNF involves an inducible autocrine cascade.

Authors:  Kevin A Janes; Suzanne Gaudet; John G Albeck; Ulrik B Nielsen; Douglas A Lauffenburger; Peter K Sorger
Journal:  Cell       Date:  2006-03-24       Impact factor: 41.582

4.  The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells.

Authors:  Hagen Kulbe; Thorsten Hagemann; Piotr W Szlosarek; Frances R Balkwill; Julia L Wilson
Journal:  Cancer Res       Date:  2005-11-15       Impact factor: 12.701

5.  CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers.

Authors:  Ilona Kryczek; Andrzej Lange; Peter Mottram; Xavier Alvarez; Pui Cheng; Melina Hogan; Lieve Moons; Shuang Wei; Linhua Zou; Véronique Machelon; Dominique Emilie; Margarita Terrassa; Andrew Lackner; Tyler J Curiel; Peter Carmeliet; Weiping Zou
Journal:  Cancer Res       Date:  2005-01-15       Impact factor: 12.701

6.  Elevated Flk1 (vascular endothelial growth factor receptor 2) signaling mediates enhanced angiogenesis in beta3-integrin-deficient mice.

Authors:  Andrew R Reynolds; Louise E Reynolds; Tobi E Nagel; Julie C Lively; Stephen D Robinson; Daniel J Hicklin; Sarah C Bodary; Kairbaan M Hodivala-Dilke
Journal:  Cancer Res       Date:  2004-12-01       Impact factor: 12.701

7.  Prognostic significance of vascular endothelial growth factor expression in ovarian cancer patients: a long-term follow-up.

Authors:  C Rudlowski; A-K Pickart; C Fuhljahn; T Friepoertner; B Schlehe; S Biesterfeld; W Schroeder
Journal:  Int J Gynecol Cancer       Date:  2006 Jan-Feb       Impact factor: 3.437

8.  Expression and regulation of tumor necrosis factor alpha in normal and malignant ovarian epithelium.

Authors:  Peter W Szlosarek; Matthew J Grimshaw; Hagen Kulbe; Julia L Wilson; George D Wilbanks; Frances Burke; Frances R Balkwill
Journal:  Mol Cancer Ther       Date:  2006-02       Impact factor: 6.261

9.  VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche.

Authors:  Rosandra N Kaplan; Rebecca D Riba; Stergios Zacharoulis; Anna H Bramley; Loïc Vincent; Carla Costa; Daniel D MacDonald; David K Jin; Koji Shido; Scott A Kerns; Zhenping Zhu; Daniel Hicklin; Yan Wu; Jeffrey L Port; Nasser Altorki; Elisa R Port; Davide Ruggero; Sergey V Shmelkov; Kristian K Jensen; Shahin Rafii; David Lyden
Journal:  Nature       Date:  2005-12-08       Impact factor: 49.962

Review 10.  Tumour necrosis factor-alpha as a tumour promoter.

Authors:  Peter Szlosarek; Kellie A Charles; Frances R Balkwill
Journal:  Eur J Cancer       Date:  2006-03-06       Impact factor: 9.162

View more
  164 in total

1.  Oncogene-driven intrinsic inflammation induces leukocyte production of tumor necrosis factor that critically contributes to mammary carcinogenesis.

Authors:  Sabina Sangaletti; Claudio Tripodo; Chiara Ratti; Silvia Piconese; Rossana Porcasi; Rosalba Salcedo; Giorgio Trinchieri; Mario P Colombo; Claudia Chiodoni
Journal:  Cancer Res       Date:  2010-10-05       Impact factor: 12.701

2.  Mesothelin overexpression promotes autocrine IL-6/sIL-6R trans-signaling to stimulate pancreatic cancer cell proliferation.

Authors:  Uddalak Bharadwaj; Christian Marin-Muller; Min Li; Changyi Chen; Qizhi Yao
Journal:  Carcinogenesis       Date:  2011-04-23       Impact factor: 4.944

3.  Cross-talk between receptor tyrosine kinase and tumor necrosis factor-α signaling networks regulates apoptosis but not proliferation.

Authors:  Elsa M Beyer; Gavin MacBeath
Journal:  Mol Cell Proteomics       Date:  2012-02-08       Impact factor: 5.911

4.  Rethinking ovarian cancer: recommendations for improving outcomes.

Authors:  Sebastian Vaughan; Jermaine I Coward; Robert C Bast; Andy Berchuck; Jonathan S Berek; James D Brenton; George Coukos; Christopher C Crum; Ronny Drapkin; Dariush Etemadmoghadam; Michael Friedlander; Hani Gabra; Stan B Kaye; Chris J Lord; Ernst Lengyel; Douglas A Levine; Iain A McNeish; Usha Menon; Gordon B Mills; Kenneth P Nephew; Amit M Oza; Anil K Sood; Euan A Stronach; Henning Walczak; David D Bowtell; Frances R Balkwill
Journal:  Nat Rev Cancer       Date:  2011-09-23       Impact factor: 60.716

5.  Targeting diphtheria toxin and TNF alpha expression in ovarian tumors using the H19 regulatory sequences.

Authors:  Aya Mizrahi; Abraham Hochberg; Smadar Amiur; Jennifer Gallula; Imad Matouk; Tatiana Birman; Tally Levy; Sorin Ladimir; Patricia Ohana
Journal:  Int J Clin Exp Med       Date:  2010-09-21

6.  Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial.

Authors:  Britton Trabert; Ligia Pinto; Patricia Hartge; Troy Kemp; Amanda Black; Mark E Sherman; Louise A Brinton; Ruth M Pfeiffer; Meredith S Shiels; Anil K Chaturvedi; Allan Hildesheim; Nicolas Wentzensen
Journal:  Gynecol Oncol       Date:  2014-08-23       Impact factor: 5.482

Review 7.  Tumor necrosis factor and cancer, buddies or foes?

Authors:  Xia Wang; Yong Lin
Journal:  Acta Pharmacol Sin       Date:  2008-11       Impact factor: 6.150

Review 8.  Cancer-related inflammation.

Authors:  Juliana Candido; Thorsten Hagemann
Journal:  J Clin Immunol       Date:  2012-12-09       Impact factor: 8.317

Review 9.  The immune system in the pathogenesis of ovarian cancer.

Authors:  Bridget Charbonneau; Ellen L Goode; Kimberly R Kalli; Keith L Knutson; Melissa S Derycke
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

Review 10.  Inflammation: a driving force speeds cancer metastasis.

Authors:  Yadi Wu; Binhua P Zhou
Journal:  Cell Cycle       Date:  2009-10-03       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.